International Open Access Journal Platform

logo
open
cover
Current Views: 163736
Current Downloads: 93402

Environment and Resource

ISSN Print:2707-2398
ISSN Online:2707-2401
Contact Editorial Office
Join Us
DATABASE
SUBSCRIBE
Journal index
Journal
Your email address

医药发展中的环境资源保护与可持续路径研究——以太极集团为例

Research on Environmental Resource Protection and Sustainable Paths in Pharmaceutical Development —A Case Study of Taiji Group

Environment and Resource / 2025,7(1): 118-134 / 2025-09-10 look6 look3
  • Authors: 马骏钊 刘陈莉 石果
  • Information:
    太极集团重庆涪陵制药厂有限公司,重庆
  • Keywords:
    Green pharmaceuticals; Sustainable development; Environmental resource protection; Taiji Group
    绿色医药; 可持续发展; 环境资源保护; 太极集团
  • Abstract: The pharmaceutical industry is a core component of the global health system, directly linked to human life and health while also indirectly influencing social and ecological security. During the production phase, the industry often faces challenges such as high energy consumption, cumulative environmental pressures, and the complex discharge of pollutants, posing significant threats to ecological systems. From the perspective of environmental resource protection and sustainable development, this study takes Taiji Group’s Chongqing Fuling Pharmaceutical Plant as a case study to examine its practical initiatives in green cultivation of medicinal materials, energy conservation and carbon reduction, full-process clean production, resource recycling, and ESG governance. On this basis, the study summarizes a development model with replicable and transferable value, analyzes the underlying mechanisms of environmental impacts throughout the pharmaceutical life cycle, and explores the institutional support for green transformation in line with national policies. Furthermore, it highlights the institutional safeguards required for enterprises to advance green transition and proposes targeted recommendations: at the enterprise level, designing tiered and classified implementation plans for green transition; and at the policy level, establishing a green drug evaluation system, expanding green financial support, and promoting effective multi-stakeholder regulatory coordination. 医药行业是全球健康体系的主要构成单元,与人类的生命健康直接关联,还能间接对社会生态安全起到影响,医药行业生产阶段,往往面临能源大量消耗、环境压力慢慢累积和污染物排放复杂等问题,对生态环境系统形成挑战,本文基于环境资源保护跟可持续发展的视角考量,择取太极集团重庆涪陵制药厂为研究案例,深入探究其在药材绿色种植、节能降碳、全流程清洁生产、资源循环利用和ESG治理等领域的实际操作。基于这一基础,概括该厂具备复制与推广意义的发展模式,解析医药产业在全生命周期里对环境产生作用的内在原理,再结合国家相关政策分析绿色转型的制度支撑要素,本文进一步剖析了医药企业推进绿色转型所需的制度保障,并按照这些情形给出针对性建议:立足企业这个层面,设计分层次分类型的绿色转型实施计划;从政策层面出发,建设绿色药品评价体系、加大绿色金融支持投入、推动多元监管协同起效。
  • DOI: https://doi.org/10.35534/er.0701009
  • Cite: 马骏钊,刘陈莉,石果.医药发展中的环境资源保护与可持续路径研究——以太极集团为例[J].环境与资源,2025,7(1):118-134.
Already have an account?
+86 027-59302486
Top